Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
Patutina OA, Gaponova Miroshnichenko SK, Sen'kova AV, Savin IA, Gladkikh DV, Burakova EA, Fokina AA, Maslov MA, Shmendel' EV, Wood MJA, Vlassov VV, Altman S, Stetsenko DA, Zenkova MA.
Patutina OA, et al.
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32370-32379. doi: 10.1073/pnas.2016158117. Epub 2020 Dec 7.
Proc Natl Acad Sci U S A. 2020.
PMID: 33288723
Free PMC article.